3-Pyridazinecarboxamide,6-[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-13c-D3-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-N-(methyl-d3)
Deucravacitinib (BMS-986165)-13C-d3 is a fully characterized chemical compound used as a reference standard of API Deucravacitinib. The standard offered is compliant with regulatory guidelines. Deucravacitinib (BMS-986165)-13C-d3 is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - NA
